Latest Expert Exchange Queries
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
 
 
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Service Tax | Sales Tax | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Indirect Tax | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing
 
 
 
 
Popular Search: ACCOUNTING STANDARDS :: ACCOUNTING STANDARD :: cpt :: form 3cd :: VAT Audit :: ARTICLES ON INPUT TAX CREDIT IN VAT :: Central Excise rule to resale the machines to a new company :: articles on VAT and GST in India :: TDS :: VAT RATES :: list of goods taxed at 4% :: due date for vat payment :: TAX RATES - GOODS TAXABLE @ 4% :: empanelment :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes
 
 
Mergers and Acquisitions »
 M&As to be favoured route for FDI in 2017
 M&As seen driving India dollar offerings as bond costs tumble
 ECRI Institute Jumpstarts Savings for Hospitals During Mergers and Acquisitions
 Swiss mergers and acquisitions thrived in 2016
 Mergers and acquisitions: No need to regulate the non-compete fee
 Sebi tightens rules for mergers & acquisitions among unlisted firms
 The 4 Biggest Trends In Mergers And Acquisitions For 2017
 How to keep calm and carry on during mergers and acquisitions
 Mergers & Acquisitions Advisory Global Market Briefing 2017
 Here Are the 5 Biggest M&A Deals of 2016
 Tech Company Mergers and Acquisitions of 2016

Pharma sector set for wave of mergers, acquisitions: EY
May, 31st 2016

The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday.

"We're going to see a high level of investments and divestments in the pharmaceuticals sector in the coming years," said Gerd Stuerz, analyst at EY.

In April, Pfizer and Allergan called off a $160-billion (144-billion-euro) tie-up to create a new world leader in pharmaceuticals ahead of Switzerland's Novartis due to a US crackdown on tax-saving mergers.

But that is unlikely to signify the end of a wave of major deals in the sector, EY said.

"Companies will sell off entire divisions or buy new ones in order to strengthen their position," said another expert Siegfried Bialojan.

In face of fierce competition, external growth is now key for many companies.

"Pharmaceutical groups can only present innovations quickly if they buy these from outside," Bialojan argued.

After a record year for M&A (mergers and acquisitions) in the pharmaceuticals sector in 2014, 2015 would have been even better if the tie-up between Pfizer and Allergan had materialised.

Bialojan predicted that mergers of a scale of around $200 billion would become the "new norm" in the sector.

A number of major deals have been signed in recent years. After its failure to acquire Allergan, Pfizer recently announced plans to buy Anacor Pharmaceuticals, a specialist in eczema treatment, for more than five billion dollars.

It is also interested in Medivation, a California-based biotechnology firm specialising in cancer treatments that is also coveted by French group Sanofi and US firm Amgen.

Also in the US, Abbott Laboratories and St. Jude Medical, leading makers of heart care and coronary devices, announced a $25 billion merger to better target the rising levels of cardiovascular disease in aging populations.

German pharmaceuticals and chemicals giant Bayer is offering 55 billion euros for Monsanto , a bid the US firm has rejected for now.

 
 
Home | About Us | Terms and Conditions | Contact Us
Copyright 2017 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Content Management System development CMS development Content Management Solutions CMS Solutions Content Management Services CMS Services CMS Software

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions